ATE461691T1 - Zusammensetzung zur kosmetischen oder pharmazeutisch-dermatologischen verwendung - Google Patents

Zusammensetzung zur kosmetischen oder pharmazeutisch-dermatologischen verwendung

Info

Publication number
ATE461691T1
ATE461691T1 AT07733952T AT07733952T ATE461691T1 AT E461691 T1 ATE461691 T1 AT E461691T1 AT 07733952 T AT07733952 T AT 07733952T AT 07733952 T AT07733952 T AT 07733952T AT E461691 T1 ATE461691 T1 AT E461691T1
Authority
AT
Austria
Prior art keywords
cosmetic
composition
pharmaceutical
skin cells
dermatological use
Prior art date
Application number
AT07733952T
Other languages
English (en)
Inventor
Laura Martelli
Mario Martelli
Original Assignee
Pharmaland S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaland S A filed Critical Pharmaland S A
Application granted granted Critical
Publication of ATE461691T1 publication Critical patent/ATE461691T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT07733952T 2006-03-13 2007-03-13 Zusammensetzung zur kosmetischen oder pharmazeutisch-dermatologischen verwendung ATE461691T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000082A ITPD20060082A1 (it) 2006-03-13 2006-03-13 Composizione ad uso cosmetico o dermatologico
PCT/IB2007/000598 WO2007105071A2 (en) 2006-03-13 2007-03-13 Composition for cosmetic or pharmaceutical-dermatological use

Publications (1)

Publication Number Publication Date
ATE461691T1 true ATE461691T1 (de) 2010-04-15

Family

ID=38509847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07733952T ATE461691T1 (de) 2006-03-13 2007-03-13 Zusammensetzung zur kosmetischen oder pharmazeutisch-dermatologischen verwendung

Country Status (10)

Country Link
US (1) US20090098226A1 (de)
EP (1) EP2004235B1 (de)
AT (1) ATE461691T1 (de)
DE (1) DE602007005464D1 (de)
DK (1) DK2004235T3 (de)
ES (1) ES2342436T3 (de)
IT (1) ITPD20060082A1 (de)
PL (1) PL2004235T3 (de)
PT (1) PT2004235E (de)
WO (1) WO2007105071A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101205234B (zh) * 2007-12-14 2010-12-29 中山大学 姜黄素-锌化合物及其固体分散体的制备方法与应用
ES2614116T3 (es) 2010-04-09 2017-05-29 Unilever N.V. Composiciones para el cuidado bucal
EP2694020B1 (de) * 2011-04-04 2019-05-08 Unilever PLC Mundpflegezusammensetzungen
GB201904469D0 (en) * 2019-03-29 2019-05-15 Givaudan Sa Cosmetic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170618B (it) * 1981-01-13 1987-06-03 Foscama Biomed Chim Farma Preparato farmacologico di frutto sio-1,6-difosfato ad azione terapeutica nei pazienti ustionati
US6051244A (en) * 1993-01-27 2000-04-18 Perricone; Nicholas V. Fructose diphosphate topical compositions
US20010051184A1 (en) * 1999-05-20 2001-12-13 Madalene C.Y. Heng Method for using soluble curcumin to inhibit phosphorylase kinase in inflammatory diseases
US20030194446A1 (en) * 2002-04-10 2003-10-16 Akes Lindy K. Zinc oxide compositions for dermatheraputics
KR20040081248A (ko) * 2003-03-14 2004-09-21 (주)에코텍 울금추출물이 함유된 기능성 한방입욕제의 제조방법
US20080254152A1 (en) * 2003-12-18 2008-10-16 Karen Elizabeth Barrett Methods for Reducing the Effects of Stress on Skin Condition
US20060039887A1 (en) * 2004-08-20 2006-02-23 Infinity2 Health Sciences, Inc. Cosmetic or pharmaceutical composition for skin care

Also Published As

Publication number Publication date
PL2004235T3 (pl) 2010-08-31
EP2004235B1 (de) 2010-03-24
EP2004235A2 (de) 2008-12-24
WO2007105071A2 (en) 2007-09-20
ITPD20060082A1 (it) 2007-09-14
WO2007105071A3 (en) 2008-04-10
ES2342436T3 (es) 2010-07-06
DE602007005464D1 (de) 2010-05-06
US20090098226A1 (en) 2009-04-16
PT2004235E (pt) 2010-06-11
DK2004235T3 (da) 2010-07-12

Similar Documents

Publication Publication Date Title
EP3501546A3 (de) Cystein-wirkstoff konjugate und ihre verwendung
ATE418959T1 (de) Topische zusammensetzun mit natrium hyaluronat fragmente und einen retinoid
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
NZ586302A (en) Pre-surgical treatment using brimonidine applied topically to reduce bleeding or bruising
BRPI0912411A2 (pt) uso de uma muteína de interleucina humana-2 (muteína de hil-2) ou de um fragmento da mesma, composição farmacêutica para o tratamento e/ou profilaxia de uma doença autoimune, uso de muteína de interleucina humana-2 (muteína de hil-2) ou de uma seção da mesma, agete para formação de células t regulatórias (treg) em um organismo, método para tratamento e/ou profilaxia de uma doença autoimune em um organismo, método para formação de células t regulatórias (treg) em um organismo, método para formação de células t regulatórias (treg) in vitro.
BR112015006828A8 (pt) composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; uso do composto; e método para modular a atividade de uma proteína ire1
EA021275B9 (ru) Гетероциклические соединения, содержащая их фармацевтическая композиция и их применение для лечения pask-опосредованного заболевания
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
BR112014006455A2 (pt) alquilamidotiazóis, preparações cosméticas ou dermatológicas com um teor de um ou vários alquilamidotiazóis e uso de um ou vários alquilamidotiazóis
RU2018135973A (ru) Фармацевтическая комбинация, содержащая метроформин и дигидрокверценин, и ее применение для лечения рака
RU2014150505A (ru) Способ идентификации лигандов рецептора ahr, которые обладают терапевтической себосупрессивной активностью, и указанные лиганды
MX2015013148A (es) Nuevos compuestos de bencensulfonamida, metodo para sintetizar los mismos, y uso de los mismos en medicina asi como tambien en cosmeticos.
WO2012116990A3 (en) Novel use
WO2012160289A3 (fr) Composition cosmétique comprenant un polymère superabsorbant et un glucide choisi parmi les oses, les oligosides et les homopolyholosides
ATE461691T1 (de) Zusammensetzung zur kosmetischen oder pharmazeutisch-dermatologischen verwendung
DE602006015449D1 (de) Verwendung von verbindungen zur induktion der synthese von sirt-proteinen bei der oder für die herstellung eines kosmetikums oder einer pharmazeutischen zusammensetzung
BRPI0607976A2 (pt) composição farmacêutica e uso de uma composição
WO2006102899A3 (en) Oxaprozin or closely related compound for the treatment and prevention of
JP2013520447A5 (de)
FR2984735B1 (fr) Composition hydratante
BR112015022265A2 (pt) composições pigmentadas para tratamento da pele
WO2007144889A3 (en) Treatment of neurofibromatosis
ATE462477T1 (de) Verwendung eines quinoa-extrakts als kosmetisches und pharmazeutisches schlankheitsmittel und/oder als mittel zur verhinderung der formierung neuer fette im menschlichen körper
Nilforoushzadeh et al. LETTER TO EDITOR: TREATMENT OF ATROPHIC CUTANEOUS LEISHMANIASIS SCAR USING AUTOLOGOUS FIBROBLASTS AND KERATINOCYTES (A CASE REPORT AND LITERATURE REVIEW)
FR2884423B1 (fr) Utilisation de la lecithine comme medicament dans le traitement du psoriasis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2004235

Country of ref document: EP